Detailed Mechanism Funding and Narrative

Years of mechanism: 2014 2015 2016 2017 2018 2019

Details for Mechanism ID: 17488
Country/Region: Malawi
Year: 2016
Main Partner: University of Malawi
Main Partner Program: College of Medicine
Organizational Type: University
Funding Agency: HHS/CDC
Total Funding: $1,000,000 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $18,630
Care: TB/HIV (HVTB) $13,230
Care: Pediatric Care and Support (PDCS) $65,790
Health Systems Strengthening (OHSS) $444,520
Testing: HIV Testing and Counseling (HVCT) $6,380
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $12,890
Treatment: Adult Treatment (HTXS) $418,300
Treatment: Pediatric Treatment (PDTX) $20,260
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HRH_PRE By Graduates: Doctors 2017 4
HRH_PRE Number of new HCW who graduated from a pre-service training institution or program as a result of PEPFAR-supported strengthening efforts, within the reporting period, by select cadre 2017 4
HRH_PRE Sum of Graduates disaggregates 2017 4
HTS_TST Age/sex: <1 2017 731
HTS_TST Age/sex: 1-9 2017 5,838
HTS_TST Age/sex: 10-14 Female 2017 1,272
HTS_TST Age/sex: 10-14 Male 2017 1,233
HTS_TST Age/sex: 15-19 Female 2017 1,063
HTS_TST Age/sex: 15-19 Male 2017 1,018
HTS_TST Age/sex: 20-24 Female 2017 893
HTS_TST Age/sex: 20-24 Male 2017 846
HTS_TST Age/sex: 25-49 Female 2017 2,580
HTS_TST Age/sex: 25-49 Male 2017 2,415
HTS_TST Age/sex: 50+ Female 2017 892
HTS_TST Age/sex: 50+ Male 2017 775
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Female 2017 4,538
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: <15 Male 2017 4,536
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Female 2017 5,428
HTS_TST Aggregated Age/sex - USE WITH HQ PERMISSION ONLY: 15+ Male 2017 5,054
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2017 19,557
HTS_TST Service Delivery Point (Facility): Inpatient 2017 1,271
HTS_TST Service Delivery Point (Facility): Other PITC 2017 5,554
HTS_TST Service Delivery Point (Facility): Pediatric 2017 3,462
HTS_TST Service Delivery Point (Facility): PMTCT 2017 5,554
HTS_TST Service Delivery Point (Facility): TB Clinics 2017 176
HTS_TST Service Delivery Point (Facility): VCT 2017 3,540
HTS_TST Sum of Age/Sex disaggregates 2017 12,987
HTS_TST Sum of Aggregated Age/Sex <15 2017 9,074
HTS_TST Sum of Aggregated Age/Sex 15+ 2017 10,482
HTS_TST Sum of Aggregated Age/Sex disaggregates 2017 19,556
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Female 2017 21
HTS_TST_POS Test Result by Age and Sex: Positive: 10-14 Male 2017 20
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Female 2017 230
HTS_TST_POS Test Result by Age and Sex: Positive: 15-19 Male 2017 220
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Female 2017 193
HTS_TST_POS Test Result by Age and Sex: Positive: 20-24 Male 2017 183
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Female 2017 558
HTS_TST_POS Test Result by Age and Sex: Positive: 25-49 Male 2017 522
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Female 2017 193
HTS_TST_POS Test Result by Age and Sex: Positive: 50+ Male 2017 167
HTS_TST_POS Test Result by Age: Positive: <1 2017 12
HTS_TST_POS Test Result by Age: Positive: 1-9 2017 94
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Female 2017 73
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive <15 Male 2017 73
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Female 2017 1,173
HTS_TST_POS Test Result by Aggregated Age and Sex: Positive 15+ Male 2017 1,092
PMTCT_ART Already on ART at beginning of current pregnancy 2017 17
PMTCT_ART New on ART 2017 16
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 204
PMTCT_EID By infants who received a virologic test within 2 months of birth 2017 11
PMTCT_EID By infants who received their first virologic HIV test between 2 and 12 months of age 2017 18
PMTCT_EID Number of infants with a positive virological test result within 12 months of birth 2017 1
PMTCT_EID Sum of Infant Age disaggregates 2017 29
PMTCT_STAT By Age (DREAMS SNUs ONLY): <15 2017 1
PMTCT_STAT By Age (DREAMS SNUs ONLY): 15-19 2017 43
PMTCT_STAT By Age (DREAMS SNUs ONLY): 20-24 2017 68
PMTCT_STAT By Age (DREAMS SNUs ONLY): 25-49 2017 69
PMTCT_STAT By Age (DREAMS SNUs ONLY): 50+ 2017 24
PMTCT_STAT By: Known positives at entry 2017 19
PMTCT_STAT By: Number of new positives identified 2017 16
PMTCT_STAT Number of new ANC and L&D clients 2017 215
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2017 204
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: <15 2017 4
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 20-24 2017 6
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 25-49 2017 7
PMTCT_STAT Required only for DREAMS Countries - By Number of known positives: 50+ 2017 2
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 15-19 2017 3
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 20-24 2017 5
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 25-49 2017 6
PMTCT_STAT Required only for DREAMS Countries - By Number of new positives: 50+ 2017 2
PMTCT_STAT Sum of Positives Status disaggregates 2017 35
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15 2017 1
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: <15-19 2017 45
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 20-24 2017 72
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 25-49 2017 72
PMTCT_STAT_den Required only for DREAMS Countries - Denominator: 50+ 2017 25
TB_ART Aggregated Age/Sex: Female <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 22
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 330
TB_ART Aggregated Age/Sex: Male <15 (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 12
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2017 182
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2017 601
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2017 547
TB_SCREENDX [Sub-Disagg of Screen Result] Specimen Sent: Specimen sent for bacteriologic diagnosis of active TB 2017 3,647
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: other (not Xpert) 2017 329
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Smear only 2017 2,983
TB_SCREENDX [Sub-Disagg of Specimen Sent] Diagnostic Test: Xpert MTB/RIF assay 2017 334
TB_SCREENDX Screen Result: Screened Positive for TB 2017 50
TB_SCREENDX Screened for TB by Age/Sex: 15+ Female 2017 3,009
TB_SCREENDX Screened for TB by Age/Sex: 15+ Male 2017 1,662
TB_SCREENDX Screened for TB by Age/Sex:<15 Female 2017 205
TB_SCREENDX Screened for TB by Age/Sex:<15 Male 2017 113
TB_SCREENDX The number of PLHIV who were screened for TB symptoms at the last clinical visit at a HIV facility during the reporting period 2017 4,989
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 38
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 562
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 21
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2017 311
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2017 932
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2017 995
TX_CURR Age/Sex: <1 2017 75
TX_CURR Age/Sex: <1-9 2017 329
TX_CURR Age/Sex: 10-14 Female 2017 76
TX_CURR Age/Sex: 10-14 Male 2017 69
TX_CURR Age/Sex: 15-19 Female 2017 173
TX_CURR Age/Sex: 15-19 Male 2017 37
TX_CURR Age/Sex: 20-24 Female 2017 544
TX_CURR Age/Sex: 20-24 Male 2017 62
TX_CURR Age/Sex: 25-49 Female 2017 2,191
TX_CURR Age/Sex: 25-49 Male 2017 1,293
TX_CURR Age/Sex: 50+ Female 2017 175
TX_CURR Age/Sex: 50+ Male 2017 228
TX_CURR Aggregated Age/Sex: <15 Female 2017 282
TX_CURR Aggregated Age/Sex: <15 Male 2017 266
TX_CURR Aggregated Age/Sex: 15+ Female 2017 2,991
TX_CURR Aggregated Age/Sex: 15+ Male 2017 1,712
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2017 5,252
TX_CURR Sum of age/sex disaggregates 2017 210
TX_CURR Sum of Aggregated Age/Sex <15 2017 548
TX_CURR Sum of Aggregated Age/Sex 15+ 2017 4,703
TX_CURR Sum of Aggregated Age/Sex disaggregates 2017 5,251
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2017 57
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2017 54
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2017 958
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2017 532
TX_NEW By Age/Sex: <1 2017 15
TX_NEW By Age/Sex: 1-9 2017 67
TX_NEW By Age/Sex: 10-14 Female 2017 15
TX_NEW By Age/Sex: 10-14 Male 2017 14
TX_NEW By Age/Sex: 15-19 Female 2017 54
TX_NEW By Age/Sex: 15-19 Male 2017 12
TX_NEW By Age/Sex: 20-24 Female 2017 169
TX_NEW By Age/Sex: 20-24 Male 2017 19
TX_NEW By Age/Sex: 25-49 Female 2017 681
TX_NEW By Age/Sex: 25-49 Male 2017 430
TX_NEW By Age/Sex: 50+ Female 2017 54
TX_NEW By Age/Sex: 50+ Male 2017 71
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2017 1,601
TX_NEW Sum of Age/Sex disaggregates 2017 1,519
TX_NEW Sum of Aggregated Age/Sex disaggregates 2017 1,601
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2017 1,838
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2017 1,654
TX_PVLS Numerator Aggregated Age/Sex: <15 Female 2017 77
TX_PVLS Numerator Aggregated Age/Sex: <15 Male 2017 72
TX_PVLS Numerator Aggregated Age/Sex: 15+ Female 2017 968
TX_PVLS Numerator Aggregated Age/Sex: 15+ Male 2017 537
TX_PVLS Numerator: Indication: Routine 2017 1,489
TX_PVLS Numerator: Indication: Targeted 2017 1
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Female 2017 85
TX_PVLS_den Denominator Aggregated Age/Sex: <15 Male 2017 80
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Female 2017 1,075
TX_PVLS_den Denominator Aggregated Age/Sex: 15+ Male 2017 597
TX_PVLS_den Denominator: Indication: Routine 2017 1,654
TX_PVLS_den Denominator: Indication: Targeted 2017 1
TX_RET Age/Sex: <1 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Age/Sex: 1-9 (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 24
TX_RET Age/Sex: 10-14 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Age/Sex: 10-14 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 5
TX_RET Age/Sex: 15-19 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 17
TX_RET Age/Sex: 15-19 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 4
TX_RET Age/Sex: 20-24 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 53
TX_RET Age/Sex: 20-24 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 6
TX_RET Age/Sex: 25-49 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 214
TX_RET Age/Sex: 25-49 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 136
TX_RET Age/Sex: 50+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 17
TX_RET Age/Sex: 50+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 22
TX_RET Aggregated Age/Sex: <15 Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 21
TX_RET Aggregated Age/Sex: <15 Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 20
TX_RET Aggregated Age/Sex: 15+ Female (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 302
TX_RET Aggregated Age/Sex: 15+ Male (Numerator: Number of adults and children who are still alive and on treatment at 12 months after initiating ART) 2017 168
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2017 511
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2017 561
TX_RET_den Age/Sex: >1 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Age/Sex: 1-9 (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 27
TX_RET_den Age/Sex: 10-14 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Age/Sex: 10-14 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 6
TX_RET_den Age/Sex: 15-19 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Age/Sex: 15-19 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 4
TX_RET_den Age/Sex: 20-24 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 59
TX_RET_den Age/Sex: 20-24 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 7
TX_RET_den Age/Sex: 25-49 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 236
TX_RET_den Age/Sex: 25-49 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 149
TX_RET_den Age/Sex: 50+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 19
TX_RET_den Age/Sex: 50+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 25
TX_RET_den Aggregated Age/Sex: <15 Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 23
TX_RET_den Aggregated Age/Sex: <15 Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 22
TX_RET_den Aggregated Age/Sex: 15+ Female (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 332
TX_RET_den Aggregated Age/Sex: 15+ Male (Denominator: Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up) 2017 185
Cross Cutting Budget Categories and Known Amounts Total: $856,421
Human Resources for Health $856,421